AzTrials
AzTrials

Suicide AttemptTREASURENCT06370104

Treating Suicidality Remotely

A study testing Brief Cognitive Behavioral Therapy for Suicide Prevention in people with Suicide Attempt, run by 113 Suicide Prevention at 1 site in Netherlands.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Background: Practical and psychological barriers make it difficult for people with Suicidal Thoughts and Behaviors (STBs) to get professional help. Online interventions have the potential to overcome many of these barriers, but the online interventions to date have produced small or short-lived effects and have only… Read more about this study

Who is it for?
Ages 16 years and older
Conditions the study is for
Suicide Attempt
What is being tested?
Brief Cognitive Behavioral Therapy for Suicide Prevention
Could I receive a placebo?
No, everyone receives an active treatment
How many people
364 participants
Where
1 siteNetherlands
Study dates
7 May 2024to 25 Apr 2028
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 16 years and older
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • 16 years or older
  • Currently living in The Netherlands
  • Any type of STBs in the past 4 weeks

Who cannot join

  • Insufficient mastery of the Dutch language
  • Previously engaged in 113 Suicide Prevention's Online Therapy or Self-help course
  • Currently seeing a mental health professional at least once every 3 weeks, other then a general practitioner or general practice based nurse practitioner ('POH-GGZ')
  • Not able to engage in online therapy, for instance because of severe mood disorders or psychotic symptoms, based on the clinical impression of the research assistant and a supervisor

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Netherlands1 site, 1 recruiting
  • 113 Suicide Prevention

    Amsterdam, South Holland, 1105BP

    Wilco Janssen, MSc, 020 3 113 883, w.janssen@113.nl

    Saskia Mérelle, PhD, 020 3 113 883, s.merelle@113.nl

    Recruiting

Other trials in Netherlands

About this study

Official title: Treating Suicidality Remotely: a Randomized Controlled Trial of Brief Cognitive Behavioral Therapy for Suicide Prevention Delivered Via Chat or Phone

Background: Practical and psychological barriers make it difficult for people with Suicidal Thoughts and Behaviors (STBs) to get professional help. Online interventions have the potential to overcome many of these barriers, but the online interventions to date have produced small or short-lived effects and have only been found to reduce suicidal thoughts, not behaviors. This is a crucial limitation, since previous studies have shown that interventions that reduce suicidal thoughts often do not prevent suicide attempts, and vice versa.

Methods: A fully remote randomized controlled trial will be conducted in which 364 participants of 16 years and older will be recruited through the website of a suicide prevention helpline in the Netherlands and randomized with an allocation ratio of 1:1 to either Brief Cognitive Behavioral Therapy for Suicide Prevention (BCBT-SP) or a semi-guided online self-help course that has previously been found superior to waitlist in reducing suicidal thoughts. The primary outcome of the study is the number of suicide attempts, measured with the Columbia Suicide Severity Rating Scale. Secondary outcomes are self-reported suicidal ideation, healthcare utilization, treatment satisfaction, adverse effects, and quality of life. All outcomes will be assessed at baseline, immediately after the treatment and at 18 months follow-up.

Discussion: If remote BCBT-SP proves effective, the findings of this study will add to the evidence base of BCBT-SP as one of very few psychological interventions with replicated effectiveness in preventing suicide attempts and provide the first evidence to date that remote interventions cannot only reduce suicidal thoughts, but also prevent suicidal behavior.

Conditions
Suicide Attempt
Being tested
Brief Cognitive Behavioral Therapy for Suicide Prevention, Living under control
Keywords
suicide, attempts, ideation, telehealth, e-health, remote, cbt, self-help
Medical subject headings
Suicide, Attempted, Suicide, Color Vision Defects

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Brief Cognitive Behavioral Therapy for Suicide PreventionBehavioural

    see arm description

  • Living under controlBehavioural

    Also called Living with deadly thoughts

    see arm description

Study groups in NCT06370104
Study groupRoleWhat they receive
Remote Brief Cognitive Behavioral Therapy for Suicide PreventionExperimentalParticipants in the experimental condition will be treated with online CBT-SP, a personalized intervention of approximately 12 sessions via chat or phone, in which therapist and client create a safety plan, try to restrict the access to lethal means and use a narrative assessment of a recent suicidal crisis to create a case formulation. This case formulation is then used to choose from several treatment modules, such as dealing with unhelpful thoughts and reducing sleep problems.
Receives: Behavioral: Brief Cognitive Behavioral Therapy for Suicide Prevention
Remote Semi-guided self-help courseActive comparatorParticipants in the control group will be treated with a self-help course, in which they are given psychoeducation on suicidal thoughts, create a safety plan and are thought several techniques from cognitive therapy, such as cognitive restructuring and worry times. The course consists of 6 sessions, on which subjects receive feedback from a therapist. In this study, feedback will be given in a live conversation with the therapist via chat or phone, instead of via e-mail, to increase safety and reduce the difference in attention between the groups.
Receives: Behavioral: Living under control

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Number of suicide attempts

    Number of fatal and non-fatal suicide attempts, identified through the Columbia Suicide Severity Rating Scale (C-SSRS; non-fatal attempts), a contact provided by the participant or Statistics Netherlands (fatal attempts).

    Measured: 18-months follow-up

Secondary outcomes (6)
  1. Severity of suicidal ideation

    Severity of suicidal ideation as measured with the suicidal ideation subscale of the Suicide Severity Rating Scale. This sub scale results in a score from 1-5 based on the most severe type of suicidal ideation endorsed by the subject. For this study, subjects who do not report any suicidal ideation are assigned a score of 0.

    Measured: 18-months follow-up

  2. Severity of suicidal Thoughts and Behaviors Composite

    A total score for STB severity will be derived from the Columbia Suicide Severity Rating Scale: subjects who report no suicidal thoughts or behaviors will be assigned a score of 0; subjects who report suicidal thoughts but not behaviors a score of 1-5, depending on their rating on the suicidal ideation subscale described above; subjects who report preparatory behavior but no attempt a score of 6; subjects who report an aborted attempt a score of 7; subjects who report an interrupted attempt a score of 8; and subjects who report a non-lethal attempt a score of 9. Subjects who have made a lethal attempt will be assigned a score of 10.

    Measured: 18-months follow-up

  3. Treatment satisfaction

    Treatment satisfaction as measured with the Client Satisfaction Questionnaire 8 (CSQ-8). The subject's scores on the 8 items of the scale are summed up, resulting in a score between 8 and 32, with higher values indicating higher satisfaction.

    Measured: post-treatment (approximately 12 weeks after the start of treatment)

  4. Adverse effects

    Adverse effects as measured with the 20-item version of the Negative Effects Questionnaire (NEQ). The mean number of negative effects that clients report and attribute to the treatment is calculated.

    Measured: post-treatment (approximately 12 weeks after the start of treatment)

  5. Co-occuring mental health issues

    Co-occuring mental health issues as measured with the MINI neuropsychiatric interview - simplified. Two scores are calculated:

    • the mean number of symptoms per client
    • the mean number of classifications per client

    Measured: 18-months follow-up

  6. Quality of life

    Quality of life as measured with the Mental Health Quality of Life Questionnaire. An overall index score is calculated by summing the scores of the seven questions. This index score can vary from 0 to 21, with higher scores indicating better quality of life.

    Measured: 18-months follow-up

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Apr 2024
  2. Study start7 May 2024
  3. Primary completion25 Apr 2028 (estimated)
  4. Study completion25 Apr 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Model description
Parallel randomized controlled trial with a 1:1 allocation ratio.
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
364 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06370104
Sponsor's protocol ID
NL85041.018.23
Acronym
TREASURE
Status last verified
May 2024
First submitted
8 Apr 2024
Last updated
20 May 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes

Publications

  • Janssen W, Merelle S, Gilissen R, Bockting C. Treating suicidality remotely (TREASURE): study protocol for a remote randomized controlled trial comparing personalized cognitive behavioral therapy for suicide prevention with a guided self-help course in adolescents and adults. Trials. 2026 Apr 22;27(1):411. doi: 10.1186/s13063-026-09725-0.

    PubMed 42015291

Questions about this trial

What is this clinical trial studying?

A study testing Brief Cognitive Behavioral Therapy for Suicide Prevention in people with Suicide Attempt, run by 113 Suicide Prevention at 1 site in Netherlands.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 20 May 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Netherlands. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Number of suicide attempts (time frame: 18-months follow-up). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06370104, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 May 2024.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in